Avaí Bio, Inc. develops cell-based therapies centered on genetically modified cell lines, protective encapsulation technologies and joint venture or licensing structures. The company, formerly Avant Technologies Inc., uses the AVAI ticker and has described a biotechnology focus spanning diabetes, age-related disorders and anti-aging applications.
Recurring developments include the Insulinova diabetes program, which pairs insulin-producing or regulating cells with encapsulation technology, and the Klothonova α-Klotho program, which uses encapsulated cells designed to produce the longevity protein α-Klotho. Company updates also cover GMP manufacturing steps such as master cell bank production, research presentations, partner collaborations and the completed corporate name change to Avaí Bio.
Avant Technologies, Inc. announced plans to equip its AI-managed data center with High-Performance Computing (HPC) systems, showcasing its commitment to advancing AI capabilities. The facility will feature cutting-edge technology, AI-driven management, and security measures to handle complex AI workloads efficiently. Avant aims to accelerate AI advancements, streamline development processes, and provide tailored solutions for clients.
Avant Technologies, Inc. (OTCQB: AVAI) has appointed William Hisey as the new CEO following the acquisition of Wired4Health, a healthcare technology and data integration firm. Hisey brings 25 years of business operations and finance experience to drive the company's growth in the AI industry. Avant has been strategically positioning itself for growth in AI data center infrastructure development.
Avant Technologies, Inc. (AVAI) plans to implement a Zero Trust Architecture (ZTA) framework powered by AI in its data centers to enhance security for customer data. The integration of AI with ZTA aims to boost security, optimize data center operations, and provide cost-effective solutions. The move aligns with Avant's commitment to innovation and technology for business optimization and security.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.